Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nelea Ghicavii"'
Autor:
Ed J. Gane, Christian Schwabe, Elina Berliba, Pisit Tangkijvanich, Alina Jucov, Nelea Ghicavii, Thierry Verbinnen, Oliver Lenz, Willem Talloen, Thomas N. Kakuda, Chris Westland, Megha Patel, Jeysen Z. Yogaratnam, Leonard Dragone, Pieter Van Remoortere
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(4)
Objectives We investigated JNJ-64530440 (a hepatitis B virus capsid assembly modulator) safety, antiviral activity and pharmacokinetics in patients with chronic hepatitis B (CHB) (Phase 1b, NCT03439488). Methods Twenty treatment-naive, HBeAg-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6900488c11a23f8eb2830d1323c9b205
https://pubmed.ncbi.nlm.nih.gov/35040959
https://pubmed.ncbi.nlm.nih.gov/35040959
Autor:
Ecaterina Luca, Irina Cosciug, Nelea Ghicavii, Valentin Calancea, Constantin Martiniuc, Svetlana Nichita, Ion Sirbu, Nicolae Bodrug, Sergiu Matcovschi
Publikováno v:
Clinical problems.
Background: In the last few years, many investigators focused their attention on the relationship between COPD and ischemic heart disease, showing that these diseases are mutually influenced. Aim: To study the dependence of myocardial ischemia on COP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f29e1ee5187780b5cb75500587d33288
https://doi.org/10.1183/13993003.congress-2020.1014
https://doi.org/10.1183/13993003.congress-2020.1014
Autor:
Ecaterina Luca, Nelea Ghicavii, Sergiu Matcovschi, Constantin Martiniuc, Ion Sirbu, Eudochia Terna, Nicolae Bodrug, Valentin Calancea, Doina Barba
Publikováno v:
Clinical problems.
Background: Pulmonary hypertension (PH), heart failure (RHF) and heart rhythm disorders (HRD), a common complications of COPD, are associated with worse clinical outcome. Aim: To study the hemodynamic effects of Diltiazem in COPD stage II-III (GOLD),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b591c1fc9fca71abb72dc38567dac6b
https://doi.org/10.1183/13993003.congress-2020.2993
https://doi.org/10.1183/13993003.congress-2020.2993
Autor:
Sergiu Matcovschi, Anatol Cretu, Natalia Antonova, Stela Oprea, Nelea Ghicavii, Valentin Calancea
Publikováno v:
Airway pharmacology and treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551621cfbfb108353feeb3d3caccdb48
https://doi.org/10.1183/13993003.congress-2019.pa2468
https://doi.org/10.1183/13993003.congress-2019.pa2468
Autor:
Doina Barba, Sergiu Matcovschi, Valentin Calancea, Tatiana Dumitras, Nelea Ghicavii, Diana Fetco-Mereuta
Publikováno v:
Airway pharmacology and treatment.
Background: Pulmonary hypertension (PH) and right heart failure are common complications of COPD. Its presence is associated with shorter survival and worse clinical outcome. Vasodilators are supposed to reduce PH and improve cardiac function. Aim: T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42d118190e315204b3507e70518db39c
https://doi.org/10.1183/13993003.congress-2019.pa2469
https://doi.org/10.1183/13993003.congress-2019.pa2469
Autor:
Nelea Ghicavii, Doina Baba, Sergiu Matcovschi, Tatiana Dumitras, Ana Popescu, Eudochia Terna, Valentin Calancea
Publikováno v:
Airway pharmacology and treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07694cb44346d4fa7ab2f2ba9c938744
https://doi.org/10.1183/13993003.congress-2019.pa2479
https://doi.org/10.1183/13993003.congress-2019.pa2479
Autor:
Tatiana Dumitras, Eudochia Terna, Sergiu Matcovschi, Valentin Calancea, Nelea Ghicavii, Nicolae Bodrug, Doina Barba
Publikováno v:
Airway Pharmacology and Treatment.
Background : Current guidelines recommend bronchodilators (Beta2-agonists, Anticholinergics, Methylxanthines) in stable COPD, which do not possess direct anti-inflammatory properties. At the same time, the efficacy of drugs that diminish the inflamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fffc3952c456d240519c373faba669c
https://doi.org/10.1183/1393003.congress-2017.oa1488
https://doi.org/10.1183/1393003.congress-2017.oa1488
Autor:
Nelea Ghicavii, Nicolae Bodrug, Anatol Cretu, Valentin Calancea, Sergiu Matcovschi, Tatiana Dumitras
Publikováno v:
Clinical Problems COPD.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21ec8f5554e547e3efb3736fbf1618f0
https://doi.org/10.1183/1393003.congress-2017.pa3645
https://doi.org/10.1183/1393003.congress-2017.pa3645
Autor:
Robert B. Nachbar, John A. Wagner, Deborah Panebianco, Valentin S. Moiseev, Zhanna Kobalava, Edward Gane, Christina Reitmann, Sorin Visan, Kristien Van Dyck, Frank J. Dutko, Martine Robberechts, Inge De Lepeleire, Wendy W. Yeh, Andreas Hüser, Zifang Guo, Christian Schwabe, Joan R. Butterton, Edward O'Mara, Markus Uhle, Iain P. Fraser, Xiaobi Huang, Nelea Ghicavii, Patricia Jumes, Serghei Popa, Amelia S. Petry, Frank Wagner
Publikováno v:
Clinical Therapeutics. 40:704-718.e6
Purpose Elbasvir (MK-8742) and grazoprevir (MK-5172; Merck & Co, Inc, Kenilworth, New Jersey) are hepatitis C virus (HCV)-specific inhibitors of the nonstructural protein 5A phosphoprotein and the nonstructural protein 3/4A protease, respectively. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859e887a63702d1bb18e52d8097ed5ca
https://doi.org/10.1016/j.clinthera.2018.03.002
https://doi.org/10.1016/j.clinthera.2018.03.002